Trove
Sign In Sign Up

Liam Ratcliffe

Person
Mentions
6
Relationships
1
Events
1
Documents
3
Search

Relationship Network

Loading... nodes
Interactive Network: Click nodes or edges to highlight connections and view details with action buttons. Drag nodes to reposition. Node size indicates connection count. Line color shows relationship strength: red (8-10), orange (6-7), yellow (4-5), gray (weak). Use legend and help buttons in the graph for more guidance.

Event Timeline

Interactive Timeline: Hover over events to see details. Events are arranged chronologically and alternate between top and bottom for better visibility.
1 total relationships
Connected Entity Relationship Type
Strength (mentions)
Documents Actions
person James Niedel
Business associate
1
1
View
Date Event Type Description Location Actions
2008-09-01 N/A Liam Ratcliffe joined New Leaf N/A View

HOUSE_OVERSIGHT_024057.jpg

This document is a page from a confidential offering memorandum for 'New Leaf Ventures III, L.P.', a healthcare and life sciences investment fund targeting $375 million in capital. It outlines the partnership structure, appointing New Leaf Venture Associates III, L.P. as the General Partner and listing five managing principals (Chambon, Delagardelle, Hunt, Lathi, and Ratcliffe). The document bears a House Oversight Committee stamp, indicating it was part of a congressional investigation document production.

Financial memorandum / private placement memorandum (page 46)
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024024.jpg

This document (page 13, Control Number 257) contains professional biographies for James Niedel and Liam Ratcliffe, executives at New Leaf Venture Partners. It details their educational backgrounds, board memberships, and extensive history in the pharmaceutical industry (GSK and Pfizer respectively), including specific successful drug developments and corporate acquisitions. The document is marked confidential and bears a House Oversight file stamp.

Corporate profile / investment team bio / house oversight document
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024012.jpg

This document is an Executive Summary for 'New Leaf Ventures III, L.P.' (NLV-III), a healthcare technology investment fund targeting $375 million in capital commitments. It details the history of the management company, New Leaf Venture Partners, outlining previous funds (NLV-I and NLV-II) and their affiliation with Sprout Group/Credit Suisse. The document lists the Managing Directors and outlines the fund's strategy to invest in 24-28 U.S.-based healthcare companies. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a congressional document production.

Investment memorandum / executive summary
2025-11-19
Analysis Source
Total Received
$0.00
0 transactions
Total Paid
$0.00
0 transactions
Net Flow
$0.00
0 total transactions
No financial transactions found for this entity. Entity linking may need to be improved.
As Sender
0
As Recipient
0
Total
0
No communications found for this entity. Entity linking may need to be improved.

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein entity

Back to Search